Follow-The-Filings

Security · featured owners

ELAN Elanco Animal Health Inc.

Health Care COM Equity as of 2026 Q2 among managers we track

  • 4 Owners
  • Max 0.9%
  • $1.7B
  • 3 reduce

ELAN (Elanco Animal Health Inc.) is held in 4 featured 13F books as of 2026 Q2. Dodge & Cox is the largest tracked holder by portfolio weight (0.87%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 0.9% (Dodge & Cox) · not free-float ownership

  1. Dodge & Cox reduce 0.87%
  2. Lee Ainslie reduce 0.02%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
Dodge & Cox 2026 Q2 0.87% Reduce −2.2% 67,397,025 $1.7B history
Ron Baron - Bamco Inc. (Baron Capital) 2026 Q2 <0.01% Reduce −27.8% 118,039 $3M history
Lee Ainslie - Maverick Capital 2026 Q2 0.02% Reduce −32.1% 98,098 $2M history
Kentucky Trust Co. - Kentucky Trust 2026 Q2 <0.01% Hold 56 $1K history

4 current · options excluded

SEC filings

Recent issuer filings from EDGAR · 3 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 2.02,9.01 Filing Doc
10-Q 10-Q FOR THE PERIOD ENDED JUNE 30, 2026 Filing Doc
8-K 5.07 Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 12 rows shown

Filed Form Detail Links
4 Period Sep 4, 2026 · 3 forms Filing Doc
4 Period Aug 21, 2026 · 3 forms Filing Doc
4 Period Aug 20, 2026 Filing Doc
4 Period Aug 18, 2026 Filing Doc
4 Period Aug 12, 2026 Filing Doc
4 Period Aug 7, 2026 · 4 forms Filing Doc
4 Period Jul 24, 2026 · 3 forms Filing Doc
4 Period Jul 10, 2026 · 3 forms Filing Doc
4 Period Jul 7, 2026 Filing Doc
4 Period Jun 30, 2026 Filing Doc
4 Period Jul 1, 2026 Filing Doc
4 Period Jun 26, 2026 · 3 forms Filing Doc

Updated 4 days ago Source: SEC EDGAR submissions All on EDGAR

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $4.42B $4.44B $4.72B
Gross profit * $2.49B $2.44B $2.59B
Gross margin * 56.3% 54.9% 55.0%
Net income -$1.23B $0.338B -$0.232B
Net margin * -27.9% 7.6% -4.9%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $3.41B $3.22B $3.46B
Total non-current assets * $10.96B $9.4B $9.9B
Total assets $14.36B $12.61B $13.36B
Total current liabilities $1.24B $1.32B $1.6B
Total non-current liabilities * $6.9B $5.2B $5.21B
Total equity $6.22B $6.1B $6.55B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $271M $541M $560M
Cash from investing -$0.169B $1.16B -$0.279B
Cash from financing -$0.083B -$1.49B -$0.275B
Net change in cash $7M $116M $77M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders